KRX Growth Companies With High Insider Ownership In September 2024

The South Korea stock market has recently experienced a downturn, falling for six consecutive sessions and shedding more than 160 points or 6 percent. Despite this volatility, growth companies with high insider ownership often present attractive opportunities due to the confidence insiders have in their own businesses.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.5%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.5%	52.1%
Bioneer (KOSDAQ:A064550)	17.5%	97.6%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Oscotec (KOSDAQ:A039200)	26.3%	122%
Vuno (KOSDAQ:A338220)	19.5%	110.9%
HANA Micron (KOSDAQ:A067310)	21.3%	106.2%
INTEKPLUS (KOSDAQ:A064290)	16.3%	96.7%
UTI (KOSDAQ:A179900)	33.1%	134.6%
Techwing (KOSDAQ:A089030)	18.7%	83.6%

Click here to see the full list of 89 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

CLASSYS (KOSDAQ:A214150)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: CLASSYS Inc. is a global provider of medical aesthetics devices with a market cap of ₩3.51 billion.

Operations: The company's revenue primarily comes from its Surgical & Medical Equipment segment, which generated ₩204.37 million.

Insider Ownership: 10.1%

Return On Equity Forecast: 28% (2027 estimate)

CLASSYS Inc. is experiencing significant earnings growth, averaging 24.7% annually over the past five years, with a forecasted annual profit increase of 22.5%. Despite revenue growth being slower than 20% per year, it still outpaces the South Korean market average of 10.4%. The stock trades at a discount of 15.4% below its estimated fair value and boasts a high return on equity forecast of 28.1% in three years, demonstrating strong insider confidence and potential for future performance improvements.

• Unlock comprehensive insights into our analysis of CLASSYS stock in this growth report.
• Insights from our recent valuation report point to the potential overvaluation of CLASSYS shares in the market.

PharmaResearch (KOSDAQ:A214450)

Simply Wall St Growth Rating: ★★★★★☆

Overview: PharmaResearch Co., Ltd., along with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea and has a market cap of ₩1.95 trillion.

Operations: The company generates revenue primarily from its Pharmaceuticals segment, which amounted to ₩296.59 billion.

Insider Ownership: 38.9%

Return On Equity Forecast: 21% (2027 estimate)

PharmaResearch has experienced robust earnings growth of 63.2% over the past year and is forecast to grow its revenue by 22.1% annually, outpacing the South Korean market average of 10.4%. Despite a highly volatile share price recently, it trades at a significant discount of 55.1% below its estimated fair value. Analysts expect the stock price to rise by 29.5%, reflecting strong insider confidence and substantial potential for future performance improvements.

• Click here and access our complete growth analysis report to understand the dynamics of PharmaResearch.
• According our valuation report, there's an indication that PharmaResearch's share price might be on the cheaper side.

Samyang Foods (KOSE:A003230)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Samyang Foods Co., Ltd. operates in the food industry both domestically and internationally, with a market cap of approximately ₩3.80 trillion.

Operations: Samyang Foods generates revenue through its food business operations in South Korea and internationally, with key segments contributing ₩385.67 billion from instant noodles, ₩13.23 billion from snacks, and ₩2.93 billion from dairy products.

Insider Ownership: 11.6%

Return On Equity Forecast: 30% (2027 estimate)

Samyang Foods has demonstrated impressive earnings growth of 127.9% over the past year and is expected to continue growing at 21.08% annually, though this is slower than the South Korean market average. The stock trades at a substantial discount of 64.5% below its estimated fair value, with analysts predicting a price increase of 41.2%. Recent events include an ex-dividend date on August 12, offering a cash dividend of KRW1500 per share on August 26, 2024.

• Get an in-depth perspective on Samyang Foods' performance by reading our analyst estimates report here.
• Our valuation report unveils the possibility Samyang Foods' shares may be trading at a discount.

Summing It All Up

• Take a closer look at our Fast Growing KRX Companies With High Insider Ownership list of 89 companies by clicking here.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com